Preoperative chemoradiotherapy for esophageal cancer enhances the postoperative systemic inflammatory response

Japanese Journal of Clinical Oncology

Volumn 36, Issue 10, 2006, Pages 632-637

  Tsujimoto, Hironori ^a   Ono, Satoshi ^a   Chochi, Kentaro ^a   Sugasawa, Hidekazu ^a   Ichikura, Takashi ^a   Mochizuki, Hidetaka ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Chemoradiotherapy; Esophagectomy; Systemic inflammatory response syndrome

Indexed keywords

CISPLATIN; FLUOROURACIL; GABEXATE MESILATE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BREATHING RATE; CANCER MORTALITY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HEART RATE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HEART RATE; HUMANS; LENGTH OF STAY; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RADIOTHERAPY DOSAGE; RESPIRATION; RISK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33750738578     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl096     Document Type: Article

References (18)

1. Mooney MM. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma. J Surg Oncol 2005;92:230-8.
2. Liu HC, Hung SK, Huang CJ, Chen CC, Chen MJ, Chang CC, et al. Esophagectomy for locally advanced esophageal cancer, followed by chemoradiotherapy and adjuvant chemotherapy. World J Gastroenterol 2005;11:5367-72.
3. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003;185:538-43.
4. Aosasa S, Ono S, Mochizuki H, Tsujimoto H, Osada S, Takayama E, et al. Activation of monocytes and endothelial cells depends on the severity of surgical stress. World J Surg 2000;24:10-6.
5. Ikuta S, Ono S, Kinoshita M, Tsujimoto H, Yamauchi A, Mochizuki H. Interleukin-18 concentration in the peritoneal fluid correlates with the severity of peritonitis. Am J Surg 2003;185:550-5.
6. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation. Crit Care Med 1996;24:163-72.
7. Pixley RA, Zellis S, Bankes P, DeLa Cadena RA, Page JD, Scott CF, et al. Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome. Crit Care Med 1995;23:41-51.
8. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 1995;75:257-77.
9. Haga Y, Beppu T, Doi K, Nozawa F, Mugita N, Ikei S, et al. Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Crit Care Med 1997;25:1994-2000.
10. Ono S, Aosasa S, Mochizuki H. Effects of a protease inhibitor on reduction of surgical stress in esophagectomy. Am J Surg 1999;177:78-82.
11. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803-4.
12. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
13. Schulze S, Sommer P, Bigler D, Honnens M, Shenkin A, Cruickshank AM, et al. Effect of combined prednisolone, epidural analgesia, and indomethacin on the systemic response after colonic surgery. Arch Surg 1992;127:325-31.
14. Oda K, Akiyama S, Ito K, Kasai Y, Fujiwara M, Sekiguchi H, et al. Perioperative prostaglandin E1 treatment for the prevention of postoperative complications after esophagectomy: A randomized clinical trial. Surg Today 2004;34:662-7.
15. Tsutsui S, Moriguchi S, Morita M, Kuwano H, Matsuda H, Mori M, et al. Multivariate analysis of postoperative complications after esophageal resection. Ann Thorac Surg 1992;53:1052-6.
16. Nagawa H, Kobori O, Muto T. Prediction of pulmonary complications after transthoracic oesophagectomy. Br J Surg 1994;81:860-2.
17. Avendano CE, Flume PA, Silvestri GA, King LB, Reed CE. Pulmonary complications after esophagectomy. Ann Thorac Surg 2002;73:922-6.
18. Doty JR, Salazar JD, Forastiere AA, Heath EI, Kleinberg L, Heitmiller RF. Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy. Ann Thorac Surg 2002;74:227-31.